Jyoti Kumari

Major Clients: Sun Pharma Industries Limited (Listed), Servier India Private Limited, Elanco India Private Limited, Colorcon Asia Private Limited.

• Assisted as a core member in the audit team and coordinated backend support during the Statutory Audit and Limited Reviews of the largest listed pharmaceutical company in India, with a consolidated annual turnover of approximately INR 52,600 crores, in accordance with Indian Accounting Standards.
• Conducted Statutory Audits of private companies in the pharmaceutical sector with annual turnovers of approximately INR 500 crores.
• Executed Tax Audits under Section 44AB of the Income Tax Act, 1961 for various entities.
• Applied relevant Ind AS and AS to key financial areas including Revenue, Impairment Testing, Payroll, Expenses, Property, Plant and Equipment, Trade Receivables, and Trade Payables.
• Performed analytical reviews and documented period-wise variances; coordinated directly with the Finance Controller to resolve key audit issues.
• Conducted impairment testing for intangible assets and plant and equipment of the listed entity in accordance with Ind AS 36 – Impairment of Assets.
• Analyzed historical trends, performed segment-wise and customer-wise variance analysis, and conducted cut-off testing on revenue to assess accuracy and completeness.
• Evaluated design and operating effectiveness of internal controls through inquiry, observation, and inspection to assess risk and material impact on financial reporting.
• Reviewed and finalized Notes to Accounts in compliance with Schedule III for both listed and unlisted companies.
• Prepared Audit Reports in accordance with CARO 2020 reporting requirements.

• Supported statutory audit procedures for companies in the manufacturing, hospital, and pharmaceutical sectors.
• Assisted in tax audits under Section 44AB of the Income Tax Act, 1961, including preparation of reports in line with ICAI guidance.
• Helped with stock audits for manufacturing businesses, focusing on basic inventory checks and documentation.
• Contributed to the drafting of Independent Auditor’s Reports and CARO 2016 disclosures, including internal control observations.
• Participated in internal audits for select manufacturing and pharmaceutical companies, providing inputs on financial and operational processes.
• Performed routine audit tasks such as vouching, ledger review, and summarizing findings.